Shanghai, China

Youguo Ling

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Oricell Therapeutics Co., Ltd.. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Youguo Ling. Retrieved from https://idiyas.com/inventor/youguo-ling

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Youguo Ling: Innovator in Immune Cell Proliferation

Introduction

Youguo Ling is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of immunology, particularly in the area of immune cell proliferation. His innovative methods have the potential to advance therapeutic strategies for various diseases.

Latest Patents

Youguo Ling holds a patent for a method aimed at promoting the proliferation of immune cells. The patent, titled "Method for promoting proliferation of immune cells," discloses a technique that involves upregulating the expression of low-density lipoprotein receptor-related proteins or fragments thereof in immune cells. This method could have important implications for enhancing immune responses.

Career Highlights

Ling is currently associated with Oricell Therapeutics Co., Ltd., where he continues to work on groundbreaking research in immunology. His expertise and innovative approaches have positioned him as a key figure in the development of new therapeutic methods.

Collaborations

He collaborates with notable colleagues, including Hao Guo and Haili Ma, who contribute to his research endeavors. Their combined efforts enhance the potential for impactful discoveries in the field.

Conclusion

Youguo Ling's work in promoting immune cell proliferation showcases his dedication to advancing medical science. His innovative methods and collaborations are paving the way for future breakthroughs in immunotherapy.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…